GPI is your trusted partner, leveraging technology to develop faster, agile, data-driven alternatives to traditional market access and pricing strategy research. Through the power of data analytics we provide high quality, curated insights and recommendations on global drug pricing and market access strategy for the pharma industry.

We have created a suite of four unique solutions designed to form an integrated offering to support price and market access strategy throughout the lifecycle, but are flexible enough to be utilised individually. GPI’s suite of technology and bespoke service offerings are powered by GPI pulse™ 2.0, our market leading biopharma data analytics platform. GPI pulse™ utilises powerful algorithms to combine multiple data streams in a way that gives unique insight into the market access journey, helping to drive effective and efficient access to medicines.

GPI’s foundation lies within its intelligently integrated price and market access data, but the strength and value is in what we are able to do with it.